Benjamin M. Scott
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benjamin M. Scott has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Nina Alperovich
NIST Global Institute for Food Security
5 shared publicationsDavid Ross
NIST Global Institute for Food Security
4 shared publications- Agustin Plasencia
Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
1 shared publication Anna M. Duraj-Thatte
Department of Biological Systems Engineering, Virginia Polytechnic Institute and State University, Blacksburg, USA
1 shared publicationBelinda S. W. Chang
Department of Cell and Systems Biology, University of Toronto, Toronto, Canada
1 shared publication- Cristina Gutiérrez-Vázquez
Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
1 shared publication
Latest Publications
- 18 June 2025
- Published by Canadian Science Publishing in Canadian Journal of Microbiology
When DNA Writing is Free: Open Tools and Strategies to Accelerate the Bioeconomy
DNA synthesis and assembly techniques have enabled the creation of validated and standardized DNA parts, used for producing proteins, enzymes, and small molecules. However, most DNA parts are governed by material transfer agreements, which restrict sharing and reuse for commercial purposes even in the absence of patents, bottlenecking innovation. DNA synthesis, crucial for producing new parts, also remains expensive and therefore inaccessible to most researchers. With the breakneck pace of digital innovations for designing and learning from biology, a new and more open approach to the physical building and testing of biology is needed. We propose the establishment of an Open Bio Research Alliance, to create and distribute open collections of DNA and other biological parts, combined with regulated and affordable DNA synthesis services. Focusing on Canada’s bioeconomy, establishing domestic DNA synthesis infrastructure would not only secure global competitiveness in engineering biology, but also safeguard biosecurity and national sovereignty over critical resources. By harnessing and supporting existing lab automation resources, the Alliance will also help scale the building and testing of engineered biological systems. Leveraging these tools and strategies, Canada is well-positioned to lead the world in open and innovative biotechnology, paving the way for a thriving bioeconomy.
- 18 June 2025
- Published by Canadian Science Publishing in Canadian Journal of Microbiology
When DNA Writing is Free: Open Tools and Strategies to Accelerate the Bioeconomy
DNA synthesis and assembly techniques have enabled the creation of validated and standardized DNA parts, used for producing proteins, enzymes, and small molecules. However, most DNA parts are governed by material transfer agreements, which restrict sharing and reuse for commercial purposes even in the absence of patents, bottlenecking innovation. DNA synthesis, crucial for producing new parts, also remains expensive and therefore inaccessible to most researchers. With the breakneck pace of digital innovations for designing and learning from biology, a new and more open approach to the physical building and testing of biology is needed. We propose the establishment of an Open Bio Research Alliance, to create and distribute open collections of DNA and other biological parts, combined with regulated and affordable DNA synthesis services. Focusing on Canada’s bioeconomy, establishing domestic DNA synthesis infrastructure would not only secure global competitiveness in engineering biology, but also safeguard biosecurity and national sovereignty over critical resources. By harnessing and supporting existing lab automation resources, the Alliance will also help scale the building and testing of engineered biological systems. Leveraging these tools and strategies, Canada is well-positioned to lead the world in open and innovative biotechnology, paving the way for a thriving bioeconomy.
- Open Access
- 21 March 2024
- Published by Elsevier in Current Research in Structural Biology
- Vol. 7, 100139
Structural and functional profile of phytases across the domains of life
- 21 March 2024
- Published by Elsevier in Current Research in Structural Biology
- Vol. 7, 100139
Open AccessStructural and functional profile of phytases across the domains of life
- Open Access
- 20 December 2023
- Published by Springer Nature
Automation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v4
Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack. Thelast stepin this version contains a supplemental video with extra context and tips, as part of the protocols.io Spotlight series, featuring conversations with protocol authors.
- 20 December 2023
- Published by Springer Nature
Open AccessAutomation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v4
Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack. Thelast stepin this version contains a supplemental video with extra context and tips, as part of the protocols.io Spotlight series, featuring conversations with protocol authors.
- Open Access
- 17 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0292401
Automation protocol for high-efficiency and high-quality genomic DNA extraction from Saccharomyces cerevisiae
Although many protocols have been previously developed for genomic DNA (gDNA) extraction from S. cerevisiae, to take advantage of recent advances in laboratory automation and DNA-barcode sequencing, there is a need for automated methods that can provide high-quality gDNA at high efficiency. Here, we describe and demonstrate a fully automated protocol that includes five basic steps: cell wall and RNA digestion, cell lysis, DNA binding to magnetic beads, washing with ethanol, and elution. Our protocol avoids the use of hazardous reagents (e.g., phenol, chloroform), glass beads for mechanical cell disruption, or incubation of samples at 100°C (i.e., boiling). We show that our protocol can extract gDNA with high efficiency both from cells grown in liquid culture and from colonies grown on agar plates. We also show results from gel electrophoresis that demonstrate that the resulting gDNA is of high quality.
- 17 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0292401
Open AccessAutomation protocol for high-efficiency and high-quality genomic DNA extraction from Saccharomyces cerevisiae
Although many protocols have been previously developed for genomic DNA (gDNA) extraction from S. cerevisiae, to take advantage of recent advances in laboratory automation and DNA-barcode sequencing, there is a need for automated methods that can provide high-quality gDNA at high efficiency. Here, we describe and demonstrate a fully automated protocol that includes five basic steps: cell wall and RNA digestion, cell lysis, DNA binding to magnetic beads, washing with ethanol, and elution. Our protocol avoids the use of hazardous reagents (e.g., phenol, chloroform), glass beads for mechanical cell disruption, or incubation of samples at 100°C (i.e., boiling). We show that our protocol can extract gDNA with high efficiency both from cells grown in liquid culture and from colonies grown on agar plates. We also show results from gel electrophoresis that demonstrate that the resulting gDNA is of high quality.
- Open Access
- 22 August 2023
- Published by Springer Nature
Automation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v3
Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack.
- 22 August 2023
- Published by Springer Nature
Open AccessAutomation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v3
Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack.
- 16 June 2023
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 1 (9) , 665-679
Engineering the gut microbiome
- 16 June 2023
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 1 (9) , 665-679
Engineering the gut microbiome
- Open Access
- 27 April 2023
- Published by Springer Nature
Automation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v2
Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack.
- 27 April 2023
- Published by Springer Nature
Open AccessAutomation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v2
Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack.
- Open Access
- 5 April 2022
- Published by Springer Nature
Automation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v1
Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack.
- 5 April 2022
- Published by Springer Nature
Open AccessAutomation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v1
Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack.
- Top Cited Papers
- 28 June 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (7) , 1212-1222
Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease
Inflammatory bowel disease (IBD) is a complex chronic inflammatory disorder of the gastrointestinal tract. Extracellular adenosine triphosphate (eATP) produced by the commensal microbiota and host cells activates purinergic signaling, promoting intestinal inflammation and pathology. Based on the role of eATP in intestinal inflammation, we developed yeast-based engineered probiotics that express a human P2Y2 purinergic receptor with up to a 1,000-fold increase in eATP sensitivity. We linked the activation of this engineered P2Y2 receptor to the secretion of the ATP-degrading enzyme apyrase, thus creating engineered yeast probiotics capable of sensing a pro-inflammatory molecule and generating a proportional self-regulated response aimed at its neutralization. These self-tunable yeast probiotics suppressed intestinal inflammation in mouse models of IBD, reducing intestinal fibrosis and dysbiosis with an efficacy similar to or higher than that of standard-of-care therapies usually associated with notable adverse events. By combining directed evolution and synthetic gene circuits, we developed a unique self-modulatory platform for the treatment of IBD and potentially other inflammation-driven pathologies.
- 28 June 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (7) , 1212-1222
Top Cited PapersSelf-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease
Inflammatory bowel disease (IBD) is a complex chronic inflammatory disorder of the gastrointestinal tract. Extracellular adenosine triphosphate (eATP) produced by the commensal microbiota and host cells activates purinergic signaling, promoting intestinal inflammation and pathology. Based on the role of eATP in intestinal inflammation, we developed yeast-based engineered probiotics that express a human P2Y2 purinergic receptor with up to a 1,000-fold increase in eATP sensitivity. We linked the activation of this engineered P2Y2 receptor to the secretion of the ATP-degrading enzyme apyrase, thus creating engineered yeast probiotics capable of sensing a pro-inflammatory molecule and generating a proportional self-regulated response aimed at its neutralization. These self-tunable yeast probiotics suppressed intestinal inflammation in mouse models of IBD, reducing intestinal fibrosis and dysbiosis with an efficacy similar to or higher than that of standard-of-care therapies usually associated with notable adverse events. By combining directed evolution and synthetic gene circuits, we developed a unique self-modulatory platform for the treatment of IBD and potentially other inflammation-driven pathologies.
- Open Access
Predicted Coronavirus Nsp5 Protease Cleavage Sites in the Human Proteome: A Resource for SARS-CoV-2 Research
Background: The coronavirus nonstructural protein 5 (Nsp5) is a cysteine protease required for processing the viral polyprotein and is therefore crucial for viral replication. Nsp5 from several coronaviruses have also been found to cleave host proteins, disrupting molecular pathways involved in innate immunity. Nsp5 from the recently emerged SARS-CoV-2 virus interacts with and can cleave human proteins, which may be relevant to the pathogenesis of COVID-19. Based on the continuing global pandemic, and emerging understanding of coronavirus Nsp5-human protein interactions, we set out to predict what human proteins are cleaved by the coronavirus Nsp5 protease using a bioinformatics approach. Results: Using a previously developed neural network trained on coronavirus Nsp5 cleavage sites (NetCorona), we made predictions of Nsp5 cleavage sites in all human proteins. Structures of human proteins in the Protein Data Bank containing a predicted Nsp5 cleavage site were then examined, generating a list of 92 human proteins with a highly predicted and accessible cleavage site. Of those, 48 are expected to be found in the same cellular compartment as Nsp5. Analysis of this targeted list of proteins revealed molecular pathways susceptible to Nsp5 cleavage and therefore relevant to coronavirus infection, including pathways involved in mRNA processing, cytokine response, cytoskeleton organization, and apoptosis. Conclusions: This study combines predictions of Nsp5 cleavage sites in human proteins with protein structure information and protein network analysis. We predicted cleavage sites in proteins recently shown to be cleaved in vitro by SARS-CoV-2 Nsp5, and we discuss how other potentially cleaved proteins may be relevant to coronavirus mediated immune dysregulation. The data presented here will assist in the design of more targeted experiments, to determine the role of coronavirus Nsp5 cleavage of host proteins, which is relevant to understanding the molecular pathology of SARS-CoV-2 infection.
Open AccessPredicted Coronavirus Nsp5 Protease Cleavage Sites in the Human Proteome: A Resource for SARS-CoV-2 Research
Background: The coronavirus nonstructural protein 5 (Nsp5) is a cysteine protease required for processing the viral polyprotein and is therefore crucial for viral replication. Nsp5 from several coronaviruses have also been found to cleave host proteins, disrupting molecular pathways involved in innate immunity. Nsp5 from the recently emerged SARS-CoV-2 virus interacts with and can cleave human proteins, which may be relevant to the pathogenesis of COVID-19. Based on the continuing global pandemic, and emerging understanding of coronavirus Nsp5-human protein interactions, we set out to predict what human proteins are cleaved by the coronavirus Nsp5 protease using a bioinformatics approach. Results: Using a previously developed neural network trained on coronavirus Nsp5 cleavage sites (NetCorona), we made predictions of Nsp5 cleavage sites in all human proteins. Structures of human proteins in the Protein Data Bank containing a predicted Nsp5 cleavage site were then examined, generating a list of 92 human proteins with a highly predicted and accessible cleavage site. Of those, 48 are expected to be found in the same cellular compartment as Nsp5. Analysis of this targeted list of proteins revealed molecular pathways susceptible to Nsp5 cleavage and therefore relevant to coronavirus infection, including pathways involved in mRNA processing, cytokine response, cytoskeleton organization, and apoptosis. Conclusions: This study combines predictions of Nsp5 cleavage sites in human proteins with protein structure information and protein network analysis. We predicted cleavage sites in proteins recently shown to be cleaved in vitro by SARS-CoV-2 Nsp5, and we discuss how other potentially cleaved proteins may be relevant to coronavirus mediated immune dysregulation. The data presented here will assist in the design of more targeted experiments, to determine the role of coronavirus Nsp5 cleavage of host proteins, which is relevant to understanding the molecular pathology of SARS-CoV-2 infection.